Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis

Genes and Development

Volumn 28, Issue 23, 2014, Pages 2585-2590

  Zeitels, Lauren R ^a,b   Acharya, Asha ^b   Shi, Guanglu ^b   Chivukula, Divya ^b   Chivukula, Raghu R ^c   Anandam, Joselin L ^d   Abdelnaby, Abier A ^d   Balch, Glen C ^d   Mansour, John C ^d   Yopp, Adam C ^d   Richardson, James A ^b,d   Mendell, Joshua T ^b,e,f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Colon cancer; Intestine; microRNA; miR 26

Indexed keywords

MICRORNA; MIRN26 MICRORNA, MOUSE; MIRN26A MICRORNA, HUMAN;

ADENOMA; ANIMAL; CARCINOGENESIS; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE MUCOSA; INTESTINE TUMOR; METABOLISM; MOUSE; PATHOPHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL CULTURE;

ADENOMA; ANIMALS; CARCINOGENESIS; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; MICE; MICE, TRANSGENIC; MICRORNAS; TUMOR CELLS, CULTURED;

EID: 84914141261     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.250951.114     Document Type: Article

References (40)

1. Barker N, van Es JH, Kuipers J, Kujala P, van Born M, Cozijensen M, Haegebarth A, Korving J, Begthel H, Peters PJ, et al. 2007. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007.
2. Beard C, Hochedlinger K, Plath K, Wutz A, Jaenisch R. 2006. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 44: 23-28.
3. Belton A, Gabrovsky A, Bae YK, Reeves R, Iacobuzio-Donahue C, Huso DL, Resar LM. 2012. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS ONE 7: e30034.
4. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. 2008. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50. Chivukula RR, Shi G, Acharya A, Mills EW, Zeitels LR, Anandam JL.
5. Chivukula RR, Shi G, Acharya A, Mills EW, Zeitels LR, Anandam JL Abdelnaby AA, Balch GC, Mansour JC, Yopp AC, et al. 2014. An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell 157: 1104-1116.
6. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. 1998. Pten is essential for embryonic development and tumour suppression. Nat Genet 19: 348-355.
7. Di Leva G, Garofalo M, Croce CM. 2014. MicroRNAs in cancer. Annu Rev Pathol 9: 287-314.
8. Fluge O, Gravdal K, Carlsen E, Vonen B, Kjellevold K, Refsum S, Lilleng R, Eide TJ, Halvorsen TB, Tveit KM, et al. 2009. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. Br J Cancer 101: 1282-1289.
9. Fussbroich B,WagenerN,Macher-Goeppinger S, Benner A, FalthM, Sultmann H, Holzer A, Hoppe-Seyler K, Hoppe-Seyler F. 2011. EZH2 depletion blocks the proliferation of colon cancer cells. PLoS ONE 6: e21651.
10. Gaedcke J, Grade M, Camps J, Sokilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Moller S, et al. 2012. The rectal cancer microRNAome-microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res 18: 4919-4930.
11. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
12. Haigis K, Sage J, Glickman J, Shafer S, Jacks T. 2006. The related retinoblastoma (pRb) and p130 proteins cooperate to regulate homeostasis in the intestinal epithelium. J Biol Chem 281: 638-647.
13. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, et al. 2009. The PTENregulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 23: 1327-1337.
14. Jung HC, Kim K. 2005. Identification of MYCBP as a b-catenin/LEF-1 target using DNA microarray analysis. Life Sci 77: 1249-1262.
15. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, et al. 2009. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361: 1437-1447.
16. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, et al. 2009. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017.
17. Li Z, Nie F, Wang S, Li L. 2011. Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. Proc Natl Acad Sci 108: 3116-3123.
18. Lin Y, Chen H, Hu Z, Mao Y, Xu X, Zhu Y, Xu X, Wu J, Li S, Mao Q, et al. 2013. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. FEBS Lett 587: 2467-2473.
19. Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q, Xu K. 2012. miR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta 1822: 1692-1704.
20. Lu J,HeML, Wang L, Chen Y, LiuX,DongQ,ChenYC, Peng Y, YaoKT, Kung HF, et al. 2011. miR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 71: 225-233.
21. Ma YL, Zhang P, Wang F, Moyer MP, Yang JJ, Liu ZH, Peng JY, Chen HQ, Zhou YK, Liu WJ, et al. 2011. Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b. J Cell Mol Med 15: 1941-1954.
22. Madison BB, Dunbar L, Qiao XT, Braunstein K, Braunstein E, Gumucio DL. 2002. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem 277: 33275-33283.
23. Mavrakis KJ, Van Der Meulen J, Wolfe AL, Liu X, Mets E, Taghon T, Khan AA, Setty M, Rondou P, Vandenberghe P, et al. 2011. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet 43: 673-678.
24. Mermelshtein A, Gerson A, Walfisch S, Delgado B, Shechter-Maor G, Delgado J, Fich A, Gheber L. 2005. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas. Br J Cancer 93: 338-345.
25. Moser AR, PitotHC,DoveWF. 1990. A dominantmutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324.
26. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M. 2009. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-1075.
27. Myant K, Sansom O. 2011a. Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex. Cell Div 6: 3.
28. Myant K, Sansom OJ. 2011b. Wnt/Myc interactions in intestinal cancer: partners in crime. Exp Cell Res 317: 2725-2731.
29. Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Moller P, Stilgenbauer S, Pollack JR, Wirth T. 2008. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood 112: 4202-4212.
30. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L, Wiuf C, Sorensen FJ, Kruhoffer M, Laurberg S, et al. 2008. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424.
31. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et al. 2008. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436.
32. Schwenk F, Baron U, Rajewsky K. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23: 5080-5081.
33. min/+ mouse: roles of osteopontin. Carcinogenesis 28: 2476-2483.
34. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 102: 15545-15550.
35. Taira T, Maeda J, Onishi T, Kitaura H, Yoshida S, Kato H, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H. 1998. AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC. Genes Cells 3: 549-565.
36. van Dongen S, Abreu-Goodger C, Enright AJ. 2008. DetectingmicroRNA binding and siRNAoff-target effects fromexpression data. NatMethods 5: 1023-1025.
37. Xiong J, Du Q, Liang Z. 2010. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 29: 4980-4988.
38. Zhang B, Liu XX, He JR, Zhou CX, Guo M, He M, Li MF, Chen GQ, Zhao Q. 2011. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 32: 2-9.
39. Zhang C, Tong J, Huang G. 2013. Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells. PLoS ONE 8: e69963.
40. Zheng G, Wang H, Zhang X, Yang Y, Wang L, Du L, Li W, Li J, Qu A, Liu Y, et al. 2013. Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS ONE 8: e83025.